How to put an end to Hepatitis B
Periodic monitoring in the HBV-infected is a must—one in 10 of those infected develop cirrhosis or cancer. Patients undergo repeated testing but get no treatment as current guidelines are restrictive, excluding nearly 60 per cent from treatment. Patients live with anxiety, fear and stigma. We must move from treating a select few to treating all HBV-positives. One pill, like tenofovir, taken daily can suppress the virus lifelong, halt transmission and prevent complications.Kalyani, Dr Basu's daughter, could have been protected with a birth dose. She was not given HBV vaccination at birth. India's birth-dose coverage is just 63 per cent. Despite being one of the cheapest vaccines and India being a major vaccine producer, the HBV vaccine is scarcely available in private markets here and public awareness is dismal. Only 4.4 per cent of Delhi's adults are fully vaccinated. Are you? Sadly, nearly one-third of health professionals aren't either. Every Indian child and adult should know: the HBV vaccine is safe, effective and for everyone.COVID taught us the power of self-testing. All close contacts of the HBV-infected must be screened. Enact anti-discrimination laws in education, workplaces and healthcare. We need HBV kits to enable one-stop testing and treatment. At least 80 per cent of diagnosed patients must be linked to free, accessible treatment. Integrating HBV services with programmes for prenatal care, non-communicable diseases, HIV and tuberculosis is essential. We must integrate hepatitis testing into routine healthcare check-ups and general population-based screening. Pregnant women should be screened for both HBV and Hepatitis C Virus (HCV)—the latter spreads only through blood contact and affects 5.5 million Indians.advertisementIndia launched the National Viral Hepatitis Control Program (NVHCP) on July 28, 2018—one of the world's largest campaigns aiming to eliminate viral hepatitis by 2030. It offers free diagnosis and treatment for HBV and HCV. While impressive work on screening has been done, the treatment uptake remains low. We need a massive awareness drive and a movement for public participation.With around 3,500 global hepatitis deaths daily—11 per cent from India—the crisis demands urgency. Every avoidable death is a call to act. Each preventable infection highlights our collective failure, and an opportunity to act. We need a society-wide approach, powered by political will, scientific leadership and strong community engagement. Let us break it down. No shame. No blame. Just a cure.—The author is Professor of Eminence, Chancellor, ILBS UniversitySubscribe to India Today Magazine- EndsTrending Reel
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
an hour ago
- The Print
All about hepatitis D, deadly viral hepatitis given a ‘cancer' tag by WHO
Hepatitis D or HDV, which only affects individuals infected with hepatitis B, is associated with a two- to six-fold higher risk of liver cancer compared to hepatitis B alone, according to the IARC. Viral hepatitis, characterised by inflammation of the liver, can be caused by the five known hepatitis viruses—A, B, C, D and E. Among these, only hepatitis B, C, and D can lead to chronic infections that significantly increase the risk of cirrhosis, liver failure, or liver cancer. New Delhi: The World Health Organisation-International Agency for Research in Cancer (WHO-IARC) has now declared hepatitis D, a little-known but deadly viral hepatitis, as carcinogenic, expressing hope that this will lead to more screening and access to new treatments. It is estimated that globally, 48 million people are affected with HDV, which in combination with the hepatitis B virus, has the highest fatality rate of all the hepatitis infections, at 20 percent. Its prevalence is highest in low- and middle-income regions in Africa and Asia, apart from the Amazon basin and India. Scientific evidence has shown that 8-37 percent, depending on the region, of those infected with hepatitis B, also have HDV. A 2024 report by the WHO had said that India had over 3.5 crore cases of viral hepatitis—including 2.98 crore hepatitis B cases—in 2022, accounting for 11.6 percent of the total disease burden globally that year. Over 1.25 lakh people, the report suggested, had died due to hepatitis B and C in India that year. Senior gastroenterologists and public health professionals suggested that HDV is largely undetected in the country, mainly because of lack of screening, and is more prevalent in some parts of east India and among people infected with HBV. 'From a public health perspective, this classification by WHO-IARC highlights the importance of incorporating HDV awareness, screening, and prevention into the existing hepatitis B prevention programme,' Dr Saswata Chatterjee, gastroenterologist with the Calcutta Medical Research Institute (CMRI), told ThePrint. With liver cancer becoming a challenging burden, screening and early detection of co-infections, such as HDV, will be crucial in reducing chronic complications of viral hepatitis, he added. Also Read: Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits HBV triggers rapid progression to end-stage liver failure Dr Piyush Ranjan, senior gastroenterologist with Sir Ganga Ram Hospital in Delhi, explained that HDV is a satellite virus that requires hepatitis B virus (HBV) for replication, causing the most aggressive form of viral hepatitis. Compared to hepatitis B and C, HDV leads to more rapid progression to cirrhosis and liver cancer. In clinical terms, explained CMRI's Dr Chatterjee, HDV occurs as a co-infection—when it is contracted simultaneously with HBV—or a superinfection—when an individual who is chronically infected with HBV becomes infected with HDV. While HBV increases the risk of developing liver complications, HDV increases this risk substantially, accelerating the progression of liver fibrosis, cirrhosis and malignancy. The mode of transmission of this hepatitis virus is similar to hepatitis B and C—through contaminated injections, mother to child, and sexual contact. Dr Vibhor Sharma, a medical oncologist with Asian Hospital, highlighted that co-dependency of HDV on HBV leads to making hepatitis worse in patients. 'HDV-triggered liver disease is more severe as it can result in end-stage liver failure in less than ten years,' he said, adding that as compared to the general population in India, this form of hepatitis is seen more commonly in intravenous drug users, HIV/AIDS patients and those with chronic HBV. The declaration by the WHO-IARC is crucial, said the medical oncologist as HDV, despite its aggressiveness in triggering liver cancers, is mostly undiagnosed and is grossly underreported in developing countries such as India. Prevention and management Clinicians say HDV is preventable at a low cost, through immunisation. The effective methods to prevent both HBV and HDV are the vaccines against hepatitis B, safe blood practices, sterilisation of medical equipment, and safe sex practices, said Dr Chatterjee. The HBV vaccine in India, as part of the Union government 's Universal Immunization Programme, was piloted in 2002-03 and then scaled up in the entire country in 2010 to protect children from the acute infection. It is now provided as part of the pentavalent vaccine at 6, 10 & 14 weeks apart from the birth dose of hepatitis B vaccine. However, a 2020 study from India said that although the coverage of third-dose hepatitis B vaccine has reached 86 percent in the country, the birth dose coverage was under 50 percent in 2015 despite high rates of institutional deliveries. The WHO says that while treatment with oral medicine can cure hepatitis C within 2 to 3 months and effectively suppress hepatitis B with life-long therapy, treatment options for hepatitis D are evolving. Sir Ganga Ram's Dr Ranjan maintained that for those already infected, management is challenging, with limited approved therapies, though newer agents like bulevirtide—an antiviral therapy especially developed against the condition—offer promise. 'The carcinogen tag will hopefully intensify global surveillance, funding, and research to curb the burden of HDV-associated liver cancer,' said the gastroenterologist. (Edited by Gitanjali Das) Also Read: Cancer warning on liquor bottles 'long overdue'. Even 'light', 'moderate' drinking poses threat
Time of India
4 hours ago
- Time of India
City doctors blame ‘long Covid' for severe viral infections that have laid Kolkata low
1 2 Kolkata: The pandemic may have ended three years ago but it continues to cast its shadow on the city's healthscape. A past history of 'long or severe' Covid may have led to long-term weakening of respiratory and immune functions, making thousands in the city more vulnerable to recurrent infections, say doctors. Additionally, rapid weather fluctuations, sudden shifts from high humidity to rain, followed by intense heat combined with elevated levels of air pollution are further weakening the body's natural defences, leading to more frequent and severe infections, they say. Most private hospitals are now running at 90% occupancy with a majority of the patients suffering from Influenza A and other viral infections. You Can Also Check: Kolkata AQI | Weather in Kolkata | Bank Holidays in Kolkata | Public Holidays in Kolkata At Woodlands Hospital, around 75% of patients currently being treated for influenza and pneumonia are Covid survivors. "Particularly those who experienced moderate to severe illness have suffered lasting architectural and functional damage in the lungs. When individuals from this group, especially the elderly, come down with flu or pneumonia, their disease tends to be more severe. The risk is further compounded if they have underlying conditions like asthma, COPD, diabetes or a history of smoking," said Dipnarayan Mukherjee, microbiology consultant at the hospital. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like New Container Houses In Chom Thong Container House | Search Ads Search Now Undo According to Rajdip Sen, consultant physician at BP Poddar Hospital, post-Covid pulmonary complications are making individuals vulnerable to lower respiratory tract infections. "About 30% of influenza and pneumonia patients here have Covid history. In many of these cases, we are observing increased disease severity, particularly among those who had moderate to severe Covid," he said. Immune dysregulation following Covid may compromise the body's ability to mount an effective defence against common respiratory pathogens, Sen said and added that these patients "often present with a more aggressive clinical course, prolonged hypoxia and delayed recovery, necessitating closer monitoring and in some cases, extended hospitalisation." Charnock Hospital internal medicine consultant Jayanta Dutta said they, too, are receiving a "significant" number of patients with a history of severe Covid, many of them elderly. "It's possible that the elderly have some residual damage like fibrosis that makes them vulnerable to infections now. We have also seen growth in lung diseases like asthma, upper respiratory tract infections and COPD among those who had long Covid. This group remains prone to pneumonia and secondary bacterial infections due to lower immunity," he added. Manipal Hospital Dhakuria has received more than hundred patients with respiratory tract infection over the past 10 days. "Long Covid has left some with lung fibrosis which may have flared up now. Lower resistance induced by Covid and comorbidities could also be a reason in the case of elderly patients. But most severe Covid patients have no trace of lung damage or else this outbreak would have been far worse," said Manipal infectious diseases physician Sayan Chakrabarty. MS Purkait, medical superintendent, Techno India DAMA Hospital said, "If those with prior history of Covid, especially the elderly, develop influenza or pneumonia within a year of Covid, the symptoms are more serious and may require hospitalization. Sometimes, the infections may co-occur, making the treatment complex and prolonged. We are seeing many such cases now."
Time of India
8 hours ago
- Time of India
Mizoram reports 5 new Covid cases, active tally rises to 6: Officials
Aizawl: At least five people have been registered in Mizoram with Covid-19 infection during the past 24 hours, state Integrated Disease Surveillance Programme (IDSP) officials said on Friday. With these new cases, the total number of active Covid-19 cases stands at six. The officials said 19 people have been infected with the coronavirus in the state so far this year. All those identified as infected are from Aizawl district. No deaths due to Covid-19 have been reported this year and none of the patients are reported to have serious symptoms. Covid-19 infections were first identified in the state this year in mid-May, when two cases were reported. The officials said last year, 73 people were infected with Covid-19.
